Loading...
Fetching results...
0 items found

A0531: CYCLONE 3: A Phase 3, randomized, double-blind, placebo-controlled study of abemaciclib in combination with abiraterone plus prednisone in men with high-risk metastatic hormone-sensitive prostate cancer (mHSPC)

Speaker
Dr. J.M. (Josep Maria) Piulats
Authors
Piulats J.M.1, Smith M.2, Matsubara N.2, Zhang T.2, Agarwal N.2, Mckay R.R.2, Johnston E.2, Sherwood S.2, Schaverien C.2, Fasnacht N.2, Lithio A.2, Nacerddine K.2, Todenhöfer T.2
Institutions
1Hospital de Llobregat, Dept. of Urology, Llobregat, Spain, 2Studienpraxis Urologie, Dept. of Medicine, Nuertingen, Germany
Event
38th Annual EAU Congress
Date – Time - Location
12 March 2023, 10:45 - 12:15, Blue Area, Room 1
Session
Abstract Session 29 - Clinical trials in progress
Topic
Prostate Cancer, metastatic - Treatment, Drug Treatment
  • © 2023 European Association of Urology
  • Disclaimer